Compass Pathways

Compass Pathways AAQS

O O AAQS de Compass Pathways (CMPS) em 11 de out. de 2026 é 4. No ano anterior, O AAQS foi 4,00 — uma variação de 0,00% (inferior).

AAQS

4

YoY

0,00%

Última atualização:

Compass Pathways tem um AAQS atual de 4.

Um alto AAQS pode ser considerado um indicativo positivo de que a empresa está se desenvolvendo com sucesso.

Os investidores podem assumir que a empresa está no caminho certo para obter lucros.

Por outro lado, é importante considerar o AAQS da ação Compass Pathways em comparação aos lucros obtidos e a outras empresas do mesmo setor. Um alto AAQS não é uma garantia absoluta de um futuro positivo. Apenas desta maneira, é possível obter uma imagem completa do desempenho da empresa.

Para melhor avaliar o desenvolvimento da empresa, é importante comparar o AAQS com outras empresas do mesmo setor. Em geral, os investidores devem sempre considerar o AAQS de uma empresa em conjunto com outros indicadores, como lucro, EBIT, fluxo de caixa e outros, para fazer uma decisão de investimento fundamentada.

A Compass Pathways AAQS História

  • 3 anos

  • 10 anos

  • 25 anos

  • Max

AAQS
Data
AAQS
1 de jan. de 2018
4,00 USD
1 de jan. de 2019
4,00 USD
1 de jan. de 2020
4,00 USD
1 de jan. de 2021
4,00 USD
1 de jan. de 2022
4,00 USD
1 de jan. de 2023
4,00 USD
1 de jan. de 2024
4,00 USD
1 de jan. de 2025
4,00 USD
A Compass Pathways AAQS História
ANOAAQSYoY
40,00%
40,00%
40,00%
40,00%
40,00%
40,00%
40,00%
4—
Aceda a estes dados via API Eulerpool

Compass Pathways Análise de ações

O que Compass Pathways faz? Compass Pathways PLC is a leading company specializing in the development of groundbreaking therapies for the treatment of mental illnesses. The company was founded in 2016 and is headquartered in London. Its goal is to revolutionize the treatment of depression and other mental illnesses. The business model of Compass Pathways is based on researching psychedelics as a potential treatment for patients suffering from severe depression and anxiety disorders. The company uses innovative approaches to precisely study the effects of psychedelics on the human brain and develop new therapy concepts and products from that. An important area of Compass Pathways is clinical research. The company collaborates closely with leading research institutions to understand the impacts of psychedelics on the human brain. The research results are then used to develop innovative methods for therapeutic use of psychedelics. Another important area of Compass Pathways is the development of therapeutic products. The company has developed a patented process for producing psilocybin, a substance found in hallucinogenic mushrooms. This process achieves a very high purity of the substance, enabling precise dosing and better control of its effects. The flagship product of Compass Pathways is COMP360, a medication based on psilocybin that is being developed for the treatment of depression. The medication is currently in clinical Phase 2 trials, showing promising results. If COMP360 receives approval, it has the potential to drastically change the way we treat depression. Compass Pathways is also active in other areas. The company conducts a range of research projects related to various psychedelic substances, including LSD and other hallucinogens. Another important area of Compass Pathways is training therapists and other professionals in the use of psychedelic substances. The company offers relevant courses to promote understanding of the therapeutic use of psychedelics and enable their safe and effective application for patient treatment. Overall, Compass Pathways is a company focused on the development of groundbreaking therapies for mental illnesses. Through combining cutting-edge research, innovative products, and professional education, the company has the potential to revolutionize the way we treat mental illnesses. Compass Pathways é uma das empresas mais populares na Eulerpool.com.

Perguntas frequentes sobre ação Compass Pathways

O AAQS de Compass Pathways é 4 em 2025.

Na Eulerpool você encontra o histórico completo do Compass Pathways de O AAQS desde 2006, com valores anuais, gráficos e análises detalhadas.

O AAQS é um indicador desenvolvido pela AlleAktien.

O AAQS é um indicador desenvolvido pela AlleAktien.

Aceda a estes dados via API Eulerpool

Qualidade — Compass Pathways

Todas as Métricas Financeiras — Compass Pathways